Ovarian cancer is one of the deadliest forms of cancer. Researchers at the Center of Excellence for Holographic Imaging at Northeastern University in Boston have used HoloMonitor technology to study how the immune system can be stimulated to fight this deadly cancer form. The research results have been published in Journal of Clinical & Cellular Immunology. The article is the first scientific article to be published in a series of articles from Northeastern University in which HoloMonitor technology play a key role.
“The collaboration with Northeastern University is a huge success. Together with our advisers, the researchers at Northeastern have done a fantastic job in chiseling out new applications for our HoloMonitor technology. The success of the collaboration means that PHI has established a strategic presence in Boston – the Capital of life science research. This permanent presence allows us to market our products to both customers and leading industry players in ways not possible from Sweden”,said CEO Peter Egelberg.